IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, E. A. M.
Right arrow Articles by Plebanski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, E. A. M.
Right arrow Articles by Plebanski, M.

 Previous Article  |  Next Article 

Infection and Immunity, March 2002, p. 1417-1421, Vol. 70, No. 3
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.3.1417-1421.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Induction of T Helper Type 1 and 2 Responses to 19-Kilodalton Merozoite Surface Protein 1 in Vaccinated Healthy Volunteers and Adults Naturally Exposed to Malaria

Edwin A. M. Lee,1* Dupeh R. Palmer,2 Katie L. Flanagan,1 William H. H. Reece,1 Kennedy Odhiambo,3 Kevin Marsh,3 Margaret Pinder,4 Michael B. Gravenor,5 Wendy A. Keitel,6 Kent E. Kester,2 Carter Diggs,7 David Kaslow,8 V. Apostolopoulos,9 W. Ripley Ballou,2 Adrian V. S. Hill,1 Urszula Krzych,2 and Magdalena Plebanski1,9

Molecular Immunology Group, Nuffield Department of Medicine, Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU,1 Institute for Animal Health, Compton, Berkshire RG20 7NN, United Kingdom,5 Department of Immunology, Walter Reed Army Institute of Research,2 Malaria Vaccine Development Program, U.S. Agency for International Development, Washington, D.C.,7 KEMRI Centre for Geographical Medicine Research (Coast), Kilifi District Hospital, Kilifi, Kenya,3 Medical Research Council Laboratories, Fajara, Banjul, The Gambia,4 Department of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, Texas,6 Laboratory of Parasitic Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland,8 Vaccines and Infectious Diseases Unit, The Austin Research Institute, Victoria 3084, Australia9

Received 18 April 2001/ Returned for modification 11 June 2001/ Accepted 24 October 2001

Plasmodium falciparum malaria is a major cause of death in the tropics. The 19-kDa subunit of P. falciparum merozoite surface protein 1 (MSP-119), a major blood stage vaccine candidate, is the target of cellular and humoral immune responses in animals and humans. In this phase I trial of MSP-119, immunization of nonexposed human volunteers with either of the two allelic forms of recombinant MSP-119 induced high levels of antigen-specific Th1 (gamma interferon) and Th2 (interleukin 4 [IL-4] and IL-10) type lymphokines. The adjustment of the antigen dose and number of immunizations regulated the level of specificity of immune responses and Th1/Th2 bias of responses induced by vaccination. Novel conserved and allelic T-cell epitopes which induced cross-strain immune responses were identified. Importantly, responses to many of these novel epitopes were also present in adults exposed to malaria, both in east (Kenya) and west Africa (The Gambia). These data suggest that epitope-specific naturally acquired MSP-119 immune responses in endemic populations can be boosted by vaccination.


* Corresponding author. Mailing address: Molecular Immunology Group, Nuffield Department of Medicine, Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, United Kingdom. Phone: (44) 1865 222301. Fax: (44) 1865 221921. E-mail: elee{at}enterprise.molbiol.ox.ac.uk.


Infection and Immunity, March 2002, p. 1417-1421, Vol. 70, No. 3
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.3.1417-1421.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2002 by the American Society for Microbiology. All rights reserved.